Brief: Orasure Receives Federal Funding For Development Of Marburg Virus Rapid Antigen Test
Dec 2 (Reuters) - OraSure Technologies OSUR.O :
* ORASURE RECEIVES FEDERAL FUNDING FOR DEVELOPMENT OF
MARBURG
VIRUS RAPID ANTIGEN TEST
* ORASURE TECHNOLOGIES : INITIAL CONTRACT AWARD, VALUED AT
ABOUT
$7.5 MILLION OVER MULTIPLE YEARS IN BASE PERIOD WITH POTENTIAL
VALUE UP TO $11 MILLION
Source text: ID:nGNX4dmytr
Further company coverage: OSUR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OraSure Technologies
See all newsOraSure Technologies Inc reports results for the quarter ended June 30 - Earnings Summary
OraSure Q2 revenue rises on higher diagnostics sales
Brief: OraSure Technologies Q2 Revenue USD 30.6 Million
OraSure Technologies Inc expected to post a loss of 27 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Wabtec, Chubb, CME Group